$AMROF, Part 1. It Moved to Delaware, Filed for an IPO, and Has 2.28 Quarters of Cash

Amaero makes the refractory powder that becomes rocket nozzles and submarine piping. FY2026 revenue went from A$3.8m to A$18.1m. Its own filing says 2.28 quarters of funding. No position, and here is why.

On 4 August 2026, two directors of a company most American investors have never heard of resigned on the same day. The announcement that explained it ran to four paragraphs. It used a phrase that does not appear in retail research notes, and that phrase is the reason this company is worth several hours of your time.

The phrase was "Foreign Ownership, Control or Influence."

That is a term of art. It comes from the Defense Counterintelligence and Security Agency, and it governs whether a company is permitted to hold a facility security clearance in the United States. A company under foreign ownership, control or influence cannot hold classified contracts without a mitigation instrument. The cleanest mitigation, the one that removes the question entirely rather than managing it, is to stop being foreign.

Amaero stopped being foreign. It completed a court approved scheme of arrangement, moved its ultimate parent from Australia to Delaware, and then, six weeks later, cleared the last two Australian directors off its board. The announcement says the reconstitution is "intended to address Foreign Ownership, Control or Influence considerations relevant to the Company's defense contracts."

Nine days before that, on 15 July, the same company confidentially submitted a draft registration statement on Form S-1 to the Securities and Exchange Commission.

Six days before that, on 1 July, it received its first production contract from Bechtel Plant Machinery Incorporated, which is the prime contractor for the United States Naval Nuclear Propulsion Program.

None of these three events was covered by any outlet I could find in English beyond a wire pickup of the press release. The company has four documents in the entire SEC EDGAR full text index, and all four of them are somebody else's filings.

This is the first of a series on Amaero. It trades in Australia as 3DA and in the United States as AMROF. I do not have a position. By the end of this piece you will understand exactly what it makes, why the Navy cares, what the Velo3D relationship is actually worth as opposed to what the headline says, and the single number in its most recent filing that makes the whole thing urgent rather than merely interesting.

That number is 2.28.

What this company physically does

Start with the object, because the object is unusual.

Amaero makes metal powder. Not powder in the sense of a fine dust you might imagine, but spherical particles of tightly controlled diameter, produced by melting a metal electrode and blowing the resulting stream apart with inert gas so that surface tension pulls each droplet into a sphere before it freezes. The process is called Electrode Induction Melting Inert Gas atomization, universally shortened to EIGA. The sphericity matters because these powders are spread in layers forty microns thick across a build plate and then selectively melted by a laser. A powder that does not flow does not spread. A powder that does not spread does not print.

The company runs three EIGA Premium atomizers at a facility at 130 Innovation Drive in McDonald, Tennessee, which is a small town outside Chattanooga. One of those atomizers is dedicated to refractory alloys. Two are dedicated to titanium. Entering fiscal 2027 that installed base represents roughly 200 metric tonnes per year of refractory alloy powder and roughly 480 metric tonnes per year of titanium alloy powder.

The titanium is the volume business. The refractory is the business that explains everything else.

Refractory metals are the metals that do not melt when everything else has. Niobium melts at 2,477 degrees Celsius. Tantalum at 3,017. Tungsten at 3,422. For comparison, the nickel superalloys that make up the hot section of a jet engine start losing structural integrity somewhere north of 1,000 degrees and are kept alive by film cooling and thermal barrier coatings. When you need a part that holds its shape in a gas stream hotter than that, with no cooling available and no time to design a cooling circuit, you reach for refractory metal.

The specific alloy that matters here is C103. Its composition is niobium with roughly ten percent hafnium and one percent titanium, which is why you will see it written as Nb-10Hf-1Ti. It was developed in the 1960s. It flew on the Apollo service module propulsion system. It has been used in rocket engine nozzle extensions for sixty years, because a nozzle extension is the canonical application: the gas is extremely hot, the part is thin, the part is large, and there is no coolant available at the exit plane because the coolant has already been used upstream.

C103 has one significant weakness. It oxidizes catastrophically in air at temperature. Bare C103 exposed to atmosphere above about 400 degrees Celsius will not merely tarnish, it will consume itself. This is why C103 parts are coated, historically with a silicide coating designated R512E. In a vacuum, which is where rocket nozzle extensions operate, the problem does not arise. In atmospheric flight, which is where hypersonic vehicles operate, it very much does, and the coating becomes a life limiting component rather than a finish.

That distinction between vacuum applications and atmospheric applications is the entire hypersonics materials debate compressed into one sentence, and I will come back to it, because it bears directly on how much of the demand narrative around this company is real.

The second thing Amaero does is called PM-HIP, which stands for Powder Metallurgy Hot Isostatic Pressing. You take metal powder, seal it in a shaped can, and subject it to high pressure and high temperature simultaneously until the powder consolidates into fully dense metal in the shape of the can. What comes out is a near net shape part with, in the company's phrasing, "forged-equivalent material properties and microstructure."

That phrase is doing enormous work, and I want to be precise about why.

A large forging requires a large forging press and a supply chain of open die and closed die forge shops. The United States has a well documented shortage of that capacity, particularly for large components in nuclear and naval applications. The forging base contracted for thirty years and the qualification burden for a new forge supplier is measured in years. PM-HIP is not a cheaper forging. It is a different route to a component with equivalent properties that does not require a forging press at all. If you believe the qualification data, it substitutes capital equipment that does not exist for capital equipment that does.

The Navy has said it believes the qualification data. According to the company's July investor presentation, the Navy "recently announced support for PM-HIP as a mature manufacturing technology and a viable alternative for large casting and forging supply chain challenges." That sentence is a company characterization of a Navy position and I have not independently sighted the Navy statement, so treat it accordingly. But the contract flow, which I will come to, is consistent with it.

How it got here, which is not the story it tells

The company's investor materials present a clean arc: build capacity, qualify powders, win defense contracts, move to America. The actual history is messier and more informative, and I think it matters for judging management.

Amaero began at Monash University in Melbourne. Monash established the Monash Centre for Additive Manufacturing in 2010. In March 2013, Professor Xinhua Wu and other MCAM staff created Amaero to commercialise what the centre was producing. Amaero International Ltd was incorporated on 21 May 2019 purely as a holding vehicle for a listing, and it floated on the ASX on 5 December 2019, raising A$8.0 million by issuing 40 million shares at twenty cents.

What listed in 2019 was not a powder company. The ASX admission describes a laser additive manufacturing bureau. Amaero printed parts for customers. It did not make the feedstock.

Monash granted two intellectual property licences dated 18 October 2019, one exclusive and global covering titanium, one non exclusive covering scandium, carrying a minimum annual fee of A$50,000 from FY2023 and a A$150,000 buyout option. That university connection is now effectively gone. The FY2025 annual report records no payments to Monash and carries no licence or patent intangibles. Monash Investment Holdings held exactly 18,315,178 shares from the IPO through FY2023, diluting passively from 11.11 percent to 4.39 percent without ever buying more, and exited the register entirely during FY2024. The original 2013 operating entity, Amaero Engineering Pty Ltd, had its Australian Business Number cancelled on 7 July 2026.

The pivot from bureau to powder was attempted first in Australia, and it failed. In July 2021 the company announced it would build a world class titanium powder plant in Australia. It revised the associated revenue guidance in September 2021, secured a lease in January 2022, and issued an update in July 2022. That plant is not what exists today. What exists today is in Tennessee.

The turn came in September 2022, when Hank Holland, managing partner of the US private equity firm Pegasus Growth Capital and then a non executive director, became Executive Chairman. The founding era chairman stepped back to a non executive seat. From that point the company reoriented around a United States manufacturing base, United States customers, and eventually a United States domicile.

I think that history should be read two ways at once, and most coverage picks one.

The unflattering reading is that this is a company that has changed its business model twice, abandoned a announced manufacturing plan in one country, and is now on its third strategy in seven years, with a share count that went from 175 million to 953 million funding the journey.

The flattering reading is that the second pivot worked. Revenue went from under half a million dollars to A$18.1 million. The capital program completed on budget. The customer list now includes a naval nuclear prime and the Department of War. A management team that abandoned a plan that was not working and executed a better one is doing its job, and the fact that the current strategy is the third one is only damning if you believe the current one is also wrong.

What I take from it is narrower and more useful: this is a private equity controlled company executing a private equity playbook. Acquire control of a listed shell with useful technology, redirect it at a defensible end market, fund it through repeated raises you lead yourself, build the asset, then exit into a deeper capital market at a higher multiple. That is not a criticism. It is a description, and it explains the redomiciliation and the S-1 far better than any of the strategic language in the presentation does.

Why this is hard to make

It is worth spending a moment on why a company can build a defensible position around what is, on its face, a commodity. Powder is powder. Except that it is not, and the reasons are physical rather than commercial.

Consider what you are asking the process to do with C103. You need to melt a metal at roughly 2,477 degrees Celsius, hold it liquid long enough to break the stream into droplets, and freeze those droplets into spheres, all without letting the melt touch anything that would contaminate it and without letting it see oxygen.

Every one of those constraints is severe at that temperature.

Take contamination first. The conventional way to melt metal for atomization is in a crucible, typically ceramic. At 2,500 degrees, niobium is aggressively reactive and will attack essentially any ceramic you put it in, dissolving the crucible into the melt. The resulting powder carries ceramic inclusions, and an inclusion in a printed part is a crack initiation site. In a rocket nozzle or a submarine component, a crack initiation site is the whole ballgame.

This is why the process Amaero uses is EIGA rather than conventional gas atomization. Electrode Induction Melting Inert Gas atomization is crucible free. A pre alloyed bar of the finished chemistry is fed downward through an induction coil, which melts only the tip. The molten metal drips directly into the gas nozzle. Nothing but the alloy itself ever touches the melt. That single design choice is what makes reactive and refractory alloys atomizable at all, and it is why you see EIGA specified for titanium and refractory work while conventional crucible atomization dominates for steels and nickel alloys.

Take oxygen second. Titanium and niobium both dissolve oxygen interstitially, meaning oxygen atoms sit in the gaps of the crystal lattice rather than forming a discrete oxide. Interstitial oxygen makes the metal harder and much more brittle. Aerospace specifications for titanium powder therefore carry hard oxygen ceilings, often in the range of 1,300 to 1,500 parts per million for Ti-6Al-4V, and every time powder is handled, sieved, or reused it picks up more. A producer's ability to hold oxygen low through melting, atomization, classification and packaging is a genuine process capability and it is not easily copied.

This is also why the Auburn qualification detail I mentioned earlier matters more than a casual reading suggests. ASTM F3635 is the specification covering additively manufactured C103. Meeting Class B after a 2200 degree Fahrenheit heat treatment means the material was assessed as built and heat treated, which is the condition a part actually flies in, rather than as loose powder in a bottle. AMS7015 and ASTM F3001 for the titanium are similarly the printed material specifications rather than feedstock specifications.

Take yield third, because yield is where the economics live. Gas atomization does not produce one particle size. It produces a distribution, and only a fraction of that distribution falls inside the window a laser powder bed fusion machine can use, typically something like 15 to 45 microns. Everything coarser has to be sold into other processes at lower value, recycled, or scrapped. When your feedstock is niobium and hafnium, the difference between a process that yields 40 percent into the useful cut and one that yields 60 percent is not a rounding error, it is the gross margin.

Amaero's own boilerplate makes exactly this claim. It says the company "has commissioned advanced gas atomization technology with an industry leading yield of AM powder." I cannot verify that claim independently and it is precisely the sort of assertion a company makes about itself, so I am recording it as a claim rather than a fact. But note that it is the correct thing to claim. A management team that understood this business would compete on yield, and a management team that did not would compete on price.

Take scale last. Three atomizers producing 680 tonnes a year sounds modest next to a steel powder plant, and it is. But refractory powder is not sold by the tonne at commodity prices. It is sold by the kilogram at prices set by the input metal and the difficulty of the process. The relevant comparison is not tonnage against a steel producer, it is whether 200 tonnes a year of refractory capacity is large or small against the total Western demand for refractory AM powder, and the honest answer is that nobody publishes that number reliably. What can be said is that 200 tonnes per year of C103 at the hafnium content described later in this piece would consume a meaningful fraction of annual world hafnium production, which tells you the capacity is not small relative to the input chain even if it looks small in absolute terms.

The Velo3D relationship, and what it is actually worth

Because the question that prompted this research was about the Velo3D supply agreement, let me deal with it directly and then explain why I think it is the least interesting thing about Amaero.

Both companies announced it on 29 April 2025. Neither has ever disclosed an execution date or an effective date. It surfaced in Velo3D's SEC filings two weeks later, on 13 May 2025, inside the supplementary slides attached to its first quarter 8-K, under a page headed "Velo3D and Amaero forge strategic alliance to propel metal 3D printing innovation."

The counterparty named in Velo3D's filing is "Amaero Advanced Materials and Manufacturing, Inc.", which is the US operating subsidiary rather than the listed parent.

The scope of exclusivity is wider than most summaries report, and the asymmetry in it is the whole point. The identical wording in both releases is that Amaero "will serve as the exclusive supplier to Velo3D for Niobium C103 and other refractory alloy powders, including Molybdenum, Tantalum, Tungsten, and Zirconium alloys" and "will be preferred supplier to Velo3D for titanium alloy powders."

So Amaero is exclusive across five refractory alloy families, not just C103, and preferred on titanium. Velo3D's side of the bargain is operational rather than financial: qualify Amaero's powders, develop proprietary print parameters exclusively for Amaero's C103 and refractory alloys across the entire Sapphire printer family, and supply those parameters with new machine sales.

Critically, the exclusivity runs one way. It binds Velo3D's purchasing. It does not bind Amaero's selling. Amaero remained free to sign parallel agreements with other counterparties and has done exactly that, with Titomic, Knust-Godwin, ADDMAN and United Performance Metals.

The only disclosed termination right belongs to Amaero. Its release states it "reserves the right to terminate the agreement if qualification of C103 and Ti64 powders is not achieved by 30 November 2025." Velo3D's release of the same day does not mention the deadline or the right. Amaero declared the condition satisfied on 8 July 2025, one hundred and forty five days early, on the strength of the Auburn testing.

Now the headline number, which deserves more scrutiny than it usually gets.

Amaero said A$35 million, "or US$22.6 Million based on the exchange rate on April 25, 2025." That implies an AUD/USD rate of 0.6457. Velo3D said "approximately $22 million" and footnoted it as "calculated based on an USD/AUS exchange rate of 0.6380 on 25 April 2025." Two counterparties, the same Australian dollar figure, the same cited date, two different exchange rates and a US$600,000 gap between the translations.

The cited date is 25 April 2025, which was Anzac Day. The Reserve Bank of Australia published no exchange rate that day.

This is a small thing and I am not suggesting anything improper. It is the kind of discrepancy that arises when two investor relations teams convert a number independently against different dealer sources. I raise it because it is a useful reminder of what this figure is: a marketing translation of an estimate, not a contracted amount.

Then on 6 August 2025, Velo3D filed again, and this is the substantive one. Auburn University's National Center for Additive Manufacturing Excellence completed qualification of Amaero's powders. The results as stated: C103 niobium met ASTM F3635 Class B after a 2200 degree Fahrenheit heat treatment, and Ti-6Al-4V met AMS7015 and ASTM F3001. Over 1,000 kilograms of powder was to be delivered to Velo3D's production floor in the third quarter of 2025.

That is a real qualification at a real independent laboratory against real published standards. It is not a memorandum of understanding. Powder that meets F3635 Class B is powder a customer can build flight hardware from without writing its own material specification first, and the heat treatment detail tells you the qualification was done on printed and post processed material rather than on the powder in the bottle.

Here is where I want to be careful, because this is where most coverage of this relationship goes wrong.

The A$35 million is not contracted revenue. Read the construction of the disclosure: the value is derived from Velo3D's own demand estimates over the five year term. There is no minimum volume commitment disclosed, no take or pay provision disclosed, and no schedule disclosed. Amaero is the exclusive supplier of C103 and refractory alloys to Velo3D, and the preferred supplier of titanium. Exclusivity of that shape is an obligation on Velo3D to buy from Amaero if it buys at all. It is not an obligation to buy.

So the correct way to hold this number is as a ceiling on a five year opportunity conditional on Velo3D's own volumes, not as a floor under Amaero's revenue.

And there is a harder confirmation of that, which I think is the single most important fact about this relationship and which I have not seen reported anywhere.

Velo3D never treated the agreement as a material definitive contract.

There is no Item 1.01 current report. There is no Exhibit 10 filing of the agreement itself. When a public company enters a material definitive agreement outside the ordinary course of business, Item 1.01 of Form 8-K requires disclosure within four business days and the contract is normally filed as an exhibit. Velo3D did neither.

More telling still: Velo3D's Form 10-K for fiscal 2025, filed 31 March 2026, contains zero occurrences of "Amaero", zero of "C103", zero of "refractory" and zero of "niobium". The five year exclusive supply agreement its own press release called a strategic alliance does not appear in its annual report.

And the audited commitments note rules out any minimum obligation affirmatively. The FY2025 10-K states that purchase obligations with suppliers "are cancellable in whole or in part prior to shipment," discloses non-cancellable purchase commitments of US$7.7 million for parts and assemblies, and then says the company "has no other commitments and contingencies, except for the operating leases." The Q1 2026 10-Q carries the same structure with the parts and assemblies figure at US$24.4 million.

There is no take or pay. There is no minimum volume. The customer's auditors have confirmed it in writing.

I want to be fair about what this does and does not mean. It does not mean the relationship is fake. The qualification happened, the powder shipped, and the exclusivity on refractory alloys is real and documented by both sides. What it means is that the A$35 million figure has no contractual force whatsoever, and that the counterparty's own accountants do not regard the arrangement as creating an obligation worth disclosing. Anyone carrying A$35 million of Velo3D revenue in a model for this company is carrying a number that exists in two press releases and nowhere else.

Which raises the counterparty question, and the counterparty question is not comfortable.

Velo3D's revenue went from US$77.4 million in 2023 to US$41.0 million in 2024. That is not a growth company having a soft year, that is revenue nearly halving. Gross margin was negative 33.9 percent in 2023, negative 5.1 percent in 2024, and negative 11.7 percent in the second quarter of 2025. The company has never, in the periods disclosed in these filings, sold a printer for more than it cost to build. Its own 8-K risk factor list includes, in order, "the company's ability to continue as a going concern" and "the company's ability to raise additional capital in the near-term."

There is genuine good news on this front and I do not want to bury it. Velo3D has moved from the over the counter market back onto Nasdaq. SEC records now list its tickers as VELO and VLDXW against exchanges Nasdaq and OTC. Anyone reading a source that still calls it VLDX is reading something stale. It guided in August 2025 to US$50 million to US$60 million of 2025 revenue, gross margin above 30 percent exiting 2025, and EBITDA profitability in the first half of 2026. If it hit those marks it is a materially different company than the one in the table above.

But note what Velo3D's other 2025 deals look like. A US$15 million master services agreement with Momentus, paid in Momentus common and convertible preferred stock rather than cash, with Velo3D's stake capped at 9.99 percent of Momentus. A US$4 million agreement with Vaya Space. These are the deal structures of a company managing its cash position carefully.

My conclusion on Velo3D as it relates to Amaero: it is a legitimate, Nasdaq listed, technically credible customer whose printers are genuinely well suited to the alloys Amaero makes, and the Auburn qualification is a real asset that outlives the commercial relationship because it is a qualification of the powder, not of the pairing. But the A$35 million should be modelled as optionality. If you are buying Amaero for the Velo3D contract, you have bought the wrong thesis.

The right thesis is on the other side of the building.

The submarine

On 1 July 2026, Amaero announced a low rate initial production contract from Bechtel Plant Machinery Incorporated for piping components supporting the submarine industrial base. The value was US$344,000.

Three hundred and forty four thousand dollars. Against a company with a market capitalization in the low hundreds of millions. On its face this is a rounding error and it would be entirely reasonable to skip past it.

Do not skip past it. Read the next sentence in the quarterly report:

"Though not announced, a total of six contracts have previously been awarded by BPMI. Between the previous work and this latest contract, work ranges from development and demonstration to first article and production."

Six prior contracts, never announced. A company that issues an ASX release for a webinar recording did not announce six contracts from a naval nuclear prime. I can think of benign reasons, principally that each was individually immaterial under the continuous disclosure threshold, and that is likely the correct explanation. But the aggregate picture it reveals is a two year qualification relationship that the market has never seen the shape of.

Understand what BPMI is. Bechtel Plant Machinery Incorporated is the prime contractor to the Naval Nuclear Propulsion Program, the joint Navy and Department of Energy organization that designs, builds and maintains the reactors in United States submarines and aircraft carriers. Naval Reactors is the most conservative engineering organization in the American government, and by reputation possibly the most conservative in the world. It is the direct institutional descendant of Rickover. Material qualification inside that program is measured in years and the program does not qualify suppliers speculatively.

The progression Amaero describes is the standard defense qualification ladder: development, then demonstration, then first article, then low rate initial production, then full rate production. Amaero has just stepped onto the fourth rung. The company's own framing is that this marks "Amaero's transition from PM-HIP validation to production."

And then the number that actually matters, from the July investor presentation:

"BPMI has previously announced estimated demand for up to 400 PM-HIP components per year to support current and near-term shipbuilding needs."

Four hundred components a year against a first production award of US$344,000. I do not know the unit economics of a submarine piping component and I am not going to invent them. But the ratio between the demonstrated award and the stated addressable demand is the largest single asymmetry in this company, and unlike the Velo3D number it is anchored on a customer's published requirement rather than a customer's demand forecast used for a press release.

This also explains the December 2025 Letter of Support from the Department of the Navy, which the company describes as having been "solidified" by the LRIP award, and it explains something else that was otherwise slightly odd. It explains why a company with a market capitalization this small bothered to spend real money redomiciling itself to Delaware.

Why a company moves countries

Between February and July 2026, Amaero executed the following sequence.

February 2026, announced its intention to redomicile to the United States. March 2026, nominated Tim Johnson to the board. May 2026, distributed the scheme booklet. 5 June 2026, obtained shareholder approval at an extraordinary general meeting. 11 June 2026, the schemes became effective and the new Delaware entity was admitted to the ASX official list. 22 June 2026, redomiciliation became effective. July 2026, completed a PCAOB audit and confidentially submitted the Form S-1.

The mechanism was a Scheme Implementation Deed, executed under section 411 of the Australian Corporations Act, and there were two schemes, one for shares and one for options. Amaero Inc., a Delaware corporation, became the ultimate parent. Existing shareholders received CHESS Depositary Interests, which continue to trade on the ASX under the same 3DA ticker.

The conversion ratio is the detail that trips people up, so hold onto it: shareholders received 40 CDIs per one share of Amaero Inc. common stock. The ASX line is priced in fortieths. When this company eventually lists in the United States, the share price Americans see will be roughly forty times the ASX quote, which converts a stock that looks like a twenty four cent penny share into something in the range of seven dollars. That is not a trivial cosmetic point. It is the difference between a security most American institutions cannot touch and one they can.

Now, the reasons the company gives for the move, taken from the July presentation, are these: alignment with United States defense and sovereign manufacturing growth, greater visibility with US customers, improved comparability against US listed peers, access to a larger investor base, potential for improved valuation and liquidity, enhanced access to lower cost debt and equity, simplification for mergers and partnerships, and positioning for a potential US listing.

All of that is the language every company uses when it redomiciles, and taken alone it would be unremarkable boilerplate.

But one bullet is not boilerplate. The presentation says the move "positions Amaero to satisfy U.S. foreign ownership, control and influence (FOCI) requirements, supporting eligibility for classified defense contracts."

And the quarterly report says the redomiciliation strengthens "its ability to pursue classified U.S. Department of War and federal contracts by mitigating foreign ownership concerns."

Classified. Not sensitive, not controlled, not ITAR restricted. Classified.

A company does not restructure its parent entity, spend A$2.8 million in a single quarter on redomiciliation and IPO costs, and clear its foreign directors off the board in order to bid work it is already eligible to bid. The FOCI language, repeated across three separate disclosures in three separate documents, is the company telling you that there is work it wants which it cannot currently hold, and that it has now removed the obstacle.

The board reconstitution on 4 August completes it. Jamie Levy and Alistair Cray, both non executive directors, resigned effective that day. Both were retained on consultancy agreements through 31 December 2026 to handle Australian investor relations and corporate advisory. That structure tells you the exits are cooperative rather than acrimonious, which is worth saying plainly, because two directors leaving on one day would otherwise be a governance flag. The board is now, in the company's words, "a fully US board."

I want to flag the thing I cannot verify, because it is the load bearing uncertainty in this section. I do not have evidence that Amaero holds or has applied for a facility security clearance. FOCI mitigation is a prerequisite for one, not a substitute. The company has told us it has removed a barrier. It has not told us it has walked through the door, and I am not going to assume it has.

The S-1

On 15 July 2026 Amaero announced it had confidentially submitted a draft registration statement on Form S-1 relating to a proposed initial public offering of shares of its common stock in the United States. Share count and price range are not yet determined. The offering is subject to market conditions and completion of SEC review. The announcement was made under Rule 135, which is the safe harbor that lets an issuer say a registration is coming without the statement itself constituting an offer.

Two things are notable about the way this was done.

First, the company completed a PCAOB audit of its historical US GAAP consolidated financial statements for calendar years 2024 and 2025, and those audited statements went into the submission. That is not a small undertaking for a company this size and it is a genuine credibility marker. A PCAOB audit of US GAAP accounts is the thing that separates companies that intend to list from companies that talk about listing.

Second, the target window. The July presentation says a potential US listing is "targeted for late CY2026 / early CY2027, subject to market conditions and the completion of the SEC review process."

That is roughly four to eight months from today.

So here is the shape of the setup. A company completes its redomiciliation, completes a PCAOB audit, files confidentially, tells you it is aiming at a listing inside twelve months, and continues to trade in the meantime on the Australian Securities Exchange at a price set by Australian retail flow and on the American over the counter market at whatever the spread allows.

I am not going to tell you that pre listing accumulation is a free lunch, because it is not, and I will get to the reasons in the section on what breaks this. But the structural observation is straightforward: the buyer base that is most likely to reprice this security is currently unable to buy it in any size.

The contract Amaero got from the Department of War

On 22 July 2026, one day after the quarterly, Amaero announced a contract valued at approximately A$6.5 million, or US$4.5 million, from the United States Department of War for the development of alternative refractory alloy powders.

The details as disclosed: a thirteen month program expected to complete in August 2027, aimed at "reducing the cost of refractory alloy powders while reducing reliance on foreign sources for critical raw materials," with progress payments based on project milestones.

Three observations.

The milestone payment structure matters more than it sounds. A development contract with progress payments is working capital positive, or at worst neutral. For a company in Amaero's cash position, and we are about to look hard at that cash position, the difference between a milestone paid program and a cost incurred then invoiced program is the difference between a contract that helps and a contract that hurts.

The stated objective is the interesting part. "Reducing reliance on foreign sources for critical raw materials" is not a description of the powder business, it is a description of the input supply chain. C103 is niobium plus hafnium. Niobium production is overwhelmingly concentrated in Brazil, where CBMM alone accounts for the substantial majority of global supply. Hafnium is scarcer and stranger: it is produced almost entirely as a by product of separating hafnium out of zirconium to make nuclear grade zirconium alloys, which means global hafnium supply is a function of nuclear fuel cladding demand and not of hafnium demand. Annual world production is measured in tens of tonnes.

If the Department of War is paying Amaero to develop alternative refractory alloy powders that reduce foreign input dependence, the most natural reading is that somebody in the department has looked at the C103 supply chain and concluded that hafnium is a chokepoint. That is a real strategic tailwind for a domestic producer. It is also, and this is the part a bull case tends to skip, an acknowledgement that the alloy Amaero is currently known for has an input problem that the government would like to engineer around.

Both of those things are true simultaneously. A programme to develop alternatives to C103 is good news for the company doing the developing and ambiguous news for the long term volume of C103 itself.

The third observation is scale. A$6.5 million against FY2026 revenue of A$18.1 million is a large single contract for this company. It is 36 percent of a year of revenue, spread across thirteen months, and it is development work rather than production, which typically carries different margin characteristics than powder sales.

The hafnium problem

I want to take the Department of War contract's stated purpose seriously, because when a government agency pays a company to reduce reliance on foreign raw materials, the interesting question is which material it means.

It means hafnium. Here is why.

C103 is nominally ten percent hafnium by weight. Hafnium is not mined. There is no hafnium mine anywhere in the world and there never has been. Hafnium occurs in zircon, the zirconium silicate mineral, at a ratio of roughly fifty parts zirconium to one part hafnium, and the two elements are chemically almost identical, which is what makes them difficult to separate and also what makes the separation necessary.

The necessity is nuclear. Zirconium has an extremely low neutron absorption cross section, which makes it the ideal material for fuel cladding in a nuclear reactor. Hafnium has an extremely high neutron absorption cross section, which makes it an excellent control rod material and a catastrophic contaminant in cladding. So the nuclear industry must separate them, and it does, at considerable expense, producing nuclear grade zirconium as the product and hafnium as the by product.

That single fact governs the entire hafnium market. World hafnium supply is set by demand for nuclear fuel cladding, not by demand for hafnium. If every hafnium consumer on earth doubled their orders tomorrow, supply would not respond, because nobody separates zircon in order to get hafnium.

The numbers, drawn from industry and trade estimates rather than a single authoritative source, so treat them as directional: total refined world hafnium production runs at roughly 70 to 75 tonnes per year. Production is concentrated in four countries, being France, the United States, China and Russia. Framatome in France is estimated at around 43 percent of world output, roughly 30 tonnes a year, which makes a single French company the largest hafnium producer on the planet.

Read that list again in the context of a Department of War contract about reducing reliance on foreign sources. The largest producer is French, which is to say allied but foreign. Two of the remaining three are China and Russia. The United States is one producer among four in a market of about 75 tonnes.

The price has behaved the way you would expect a chokepoint to behave. Hafnium has risen roughly eightfold since 2020. It reached the range of US$6,300 to US$7,000 per kilogram in Rotterdam by late 2025 and has been quoted above US$12,000 per kilogram on some dealer benchmarks in early 2026. One reference series has it moving from US$4,364.80 per kilogram in January 2025 to US$9,499.90 in January 2026, a gain of about 118 percent in a year.

Now do the arithmetic that the company does not do for you. At ten percent hafnium content, one kilogram of C103 contains one hundred grams of hafnium. At US$9,500 per kilogram, that is US$950 of hafnium in every kilogram of alloy. At the US$12,000 dealer prints, it is US$1,200. Before you have paid for niobium, before you have melted anything, before you have run a single kilowatt through an induction coil, and before anybody has earned a margin.

That is the cost structure of C103, and it is the reason the Department of War is funding alternatives.

Projected demand adds the second half of the picture. Estimates put hafnium demand near 180 to 190 tonnes by 2030 against a supply base struggling to exceed 75 tonnes. The 2023 gap was already estimated at 44 to 49 tonnes. If those projections are anywhere near right, the gap by 2030 exceeds 105 tonnes, which is more than current world production.

For Amaero this cuts three ways and an honest analysis has to hold all three at once.

It is bullish in the sense that a company already qualified on a hafnium bearing alloy, in a market where the input is scarce and Western supply is thin, sits on the right side of a structural shortage. Scarcity of input is a barrier to entry for everyone, including the entrants.

It is bearish in the sense that Amaero has not disclosed secured hafnium supply. A converter buying a scarce input at spot and selling a qualified output on multi year agreements is exposed on both sides of the trade. If hafnium doubles again and Amaero's supply agreements do not have pass through provisions, the margin on C103 goes to the input, not to the shareholder. I have seen no disclosure on this either way, which is itself the finding.

And it is ambiguous in the sense that the Department of War is paying to engineer around the problem. If that thirteen month programme succeeds in delivering an alternative refractory alloy powder with less hafnium or none, then the long term volume of C103 specifically may be lower than the hypersonics narrative implies, even as Amaero is the company being paid to build the replacement. Being paid to obsolete your own product is a better position than having somebody else paid to do it, but it is not the same as unbounded C103 demand.

The single most valuable disclosure Amaero could make, and the one I will be looking for in the Form S-1, is the structure of its raw material supply. An S-1 risk factor section has to address input concentration. An ASX announcement does not.

The forging base

The other half of the business needs the same treatment, because the PM-HIP opportunity rests on a supply chain failure most investors have never had reason to learn about.

The United States lost its heavy forging capacity gradually and then structurally. Large open die and closed die forging requires enormous presses, and the number of presses in the Western hemisphere capable of the largest naval and nuclear components is small enough to count. Those presses are old, they are heavily booked, and the qualification burden to add a new supplier into a naval nuclear application runs to years. The consequence is lead times measured in years for components that a shipbuilding programme needs on a schedule.

This is not a marginal issue for the Navy. It is one of the primary constraints on submarine production rate, and submarine production rate is currently a matter of national policy attention given the Virginia class build rate, the Columbia class ballistic missile submarine programme, and the commitments made under the trilateral security arrangement with Australia and the United Kingdom.

PM-HIP addresses it from a different direction. Rather than deforming a large billet under a press, you consolidate powder in a shaped container under isostatic pressure and temperature. The result is a near net shape component with a fine, uniform, isotropic microstructure and no directional grain flow, which for many applications is equivalent to or better than a forging. Crucially, it does not need a forging press. It needs a hot isostatic press, powder, and a qualified process.

The reason this has not simply replaced forging everywhere is qualification. Naval nuclear components are governed by material specifications written decades ago that assume a wrought product form. Getting a PM-HIP component accepted means demonstrating equivalence across mechanical properties, fracture toughness, weldability and inspection response, and doing it to the satisfaction of an organisation with an institutional memory that treats novelty as risk.

Which is what makes the July disclosures significant. The Navy has, according to the company and corroborated by trade press coverage, recognised PM-HIP as a mature and well established process that meets rigorous technical requirements and compresses production timelines, and has described it as a viable alternative for large casting and forging supply chain challenges. The Maritime Industrial Base Program is described as facing long lead times and capacity constraints in exactly that supply chain.

So the sequence reads: the Navy has a forging bottleneck, the Navy has blessed PM-HIP as a route around it, BPMI has published a requirement for up to 400 PM-HIP components a year, and Amaero has just moved from first article to low rate initial production after seven contracts and two years of work.

The gap between US$344,000 of production revenue and 400 components a year is the entire investment case for this half of the business. I want to be careful not to let the size of the addressable number do the work of an argument. Amaero is not the only company capable of PM-HIP, the 400 component requirement is not exclusively addressable by any one supplier, and low rate initial production is a rung on a ladder rather than a destination. But the direction of travel is documented in primary sources, and the customer is the least promotional organisation in American industry.

The numbers

Now the financial position, which I have taken entirely from the Appendix 4C and the quarterly activities report filed on 22 July 2026, and from the FY2025 annual report filed 18 September 2025. Amaero's fiscal year ends 30 June.

Revenue first.

FY2024 revenue was A$463,856. FY2025 was A$3.8 million. FY2026 was A$18.1 million. That is a 376 percent increase on FY2025, and it landed inside the A$18 million to A$20 million guidance the company gave in January 2026, which is worth noting because guidance that is met is a data point about management quality independent of the absolute number.

The quarterly path inside FY2026 is not a smooth ramp and the shape tells you something.

Q1 A$4.7 million, Q2 A$3.1 million, Q3 A$2.6 million, Q4 A$7.8 million. Revenue went down for two consecutive quarters in the middle of a year that finished up 376 percent. That is what a business looks like when individual orders are large relative to total revenue and shipment timing dominates. It is also a warning about extrapolating any single quarter in this company.

Q4 would have been A$9.1 million and the full year A$19.5 million except that A$1.3 million of contracted titanium orders were pushed into Q1 FY2027 by a production pause I will describe shortly.

The trailing twelve month view smooths it out.

A$7.4 million, A$9.9 million, A$11.8 million, A$18.1 million. Year on year TTM growth at each of those points was 313, 384, 347 and 376 percent.

FY2026 revenue splits into A$15.6 million of powder and A$2.6 million of PM-HIP. PM-HIP is fourteen percent of revenue and it is the segment attached to the submarine industrial base, which means the strategically most important business line is currently the smaller one. In Q4 specifically, growth was supported by shipments of 30 PM-HIP components plus titanium and refractory powders across 19 unique customers.

Backlog next, and note the date carefully because the company gives two.

Backlog at 30 June 2026 was A$14.6 million. Between then and 22 July the company added approximately A$8.5 million, which includes the A$6.5 million Department of War contract and A$1.8 million of refractory powder work. Total backlog as of 22 July was A$23.1 million, of which A$12.9 million relates to work currently scheduled for completion by 31 December 2026. Backlog spans 26 unique customers. The company also discloses 28 or more tonnes of titanium powder contracted for the third calendar quarter of 2026.

A$23.1 million of backlog against A$18.1 million of trailing revenue is a healthy ratio for a company at this stage. The A$12.9 million scheduled by year end is the number to hold management against at the December quarterly.

Then capacity, which is the part of the story where the capital has already been spent.

Capacity went from 200 tonnes per year in June 2024 to 440 in June 2025 to 680 in June 2026, with 920 guided for June 2027 once the fourth EIGA atomizer commissions. Capital deployed tracked it: A$18.2 million, A$51.6 million, A$80.0 million, and A$94.0 million guided.

The company completed its original three year A$72 million capital investment program in the June quarter, on schedule and on budget, with the commissioning of the third EIGA atomizer ahead of schedule. The next phase is the fourth atomizer plus an argon gas recycling plant, the latter expected to commission in early calendar 2027. Argon recycling is an operating cost item rather than a capacity item and it matters because inert gas consumption is one of the larger variable costs in gas atomization.

Completing a multi year capital program on budget is genuinely uncommon in small cap industrials and management deserves credit for it. It also means the story from here is no longer about building capacity. It is about filling it. At A$18.1 million of revenue against 680 tonnes of installed capacity, utilization is low. Whether that gap closes is the entire question.

The number that makes this urgent

Here is the Appendix 4C.

Liquidity at 30 June 2026 against the quarter's cash consumption.

Cash and cash equivalents at 30 June 2026: A$19.43 million. Down from A$33.42 million at 31 March. Net cash used in operating activities in the quarter: A$10.90 million. For the full year: A$35.28 million. Net cash used in investing activities in the quarter: A$9.38 million. For the full year: A$36.44 million. Net cash from financing for the year: A$74.61 million.

Total financing facilities A$37.98 million, drawn A$32.56 million, undrawn A$5.41 million.

Item 8.5 of the Appendix 4C requires an entity with negative operating cash flow to state its estimated quarters of funding available. Amaero's answer is 2.28.

The arithmetic is item 8.4 divided by item 8.1: total available funding of A$24.84 million, being cash of A$19.43 million plus undrawn facilities of A$5.41 million, divided by quarterly operating cash use of A$10.90 million.

Two points about that ratio, one in the company's favour and one against.

In its favour: the denominator includes A$2.8 million of non recurring IPO and redomiciliation costs and A$0.4 million of costs related to the May manufacturing incidents. Adjusted general and administrative expense was A$6.0 million in Q4 against A$5.9 million in Q3, so the underlying cost base is flat rather than escalating. Strip the one off items and the burn rate looks materially better.

Against: the 2.28 figure counts operating cash use only. It excludes investing activities entirely. Amaero spent A$9.38 million on investing in the same quarter. Total cash consumption, operating plus investing, was A$20.28 million against A$24.84 million of available funding. On that basis the company has closer to one and a quarter quarters, not two and a quarter, unless capital expenditure stops.

Capital expenditure will slow, because the three year program is complete. But the fourth atomizer and the argon recycler are both ordered.

There is one more wrinkle. The investor presentation shows a different set of cash numbers than the 4C, and the difference is not an error in either document.

The presentation shows A$38.3 million at 31 March and A$25.2 million at 30 June. The 4C shows A$33.4 million and A$19.4 million. The gap is restricted cash: A$4.9 million at March and A$5.8 million at June, held under the terms of the Export-Import Bank facility. The footnote states that restricted cash "becomes available to fund principal and interest payments once Amaero achieves a 1.2x debt service coverage ratio."

So the restricted balance is not available to fund operations. It is collateral. The A$19.43 million in the 4C is the spendable number and it is the one I have used throughout. Anyone quoting A$25.2 million as Amaero's cash position is quoting a figure that includes A$5.8 million the company cannot spend.

The presentation also shows a further A$4.7 million EXIM disbursement for previously incurred capital expenses expected in July 2026, which takes pro forma cash to A$29.9 million on the inclusive basis, or roughly A$24.1 million on the spendable basis.

On the debt itself: the EXIM Bank credit agreement was signed in February 2025 at US$22.8 million and amended in June 2026 to US$26.1 million, an increase of US$3.3 million providing US$2.9 million of additional net cash after the exposure fee. A fixed rate of 5.36 percent was locked at execution, giving a total effective rate of approximately 8 percent. Interest payments commence 30 September 2026 and are quarterly thereafter. Principal repays in twenty eight quarterly instalments beginning 30 September 2027 and ending 30 June 2034. The facility reflects a 75 percent loan to cost advance on capital equipment at the Tennessee facility.

Note the date. Interest payments begin next month. Principal begins in thirteen months. This is non dilutive capital, which is genuinely valuable, but it is capital that starts demanding cash back on a fixed schedule starting almost immediately.

Put the whole picture together and the S-1 stops looking like a strategic option and starts looking like a requirement. A company with roughly two quarters of operating runway, capital equipment on order, interest payments starting next month, and a stated intention to list in late calendar 2026 or early 2027 is a company that needs the listing to happen roughly on schedule.

That is not a criticism. It is the single most important thing to understand about the timeline, and it cuts both ways. It means management is highly motivated to deliver contract news into the registration window. It also means the company has limited ability to wait out a bad market.

Who owns this

The FY2025 annual report discloses 690,670,634 fully paid ordinary shares at 30 June 2025, up from 542,912,442 a year earlier, with issued capital of A$122.6 million against A$77.4 million. Roughly 148 million shares were issued during FY2025 raising approximately A$45 million. FY2026 financing activities brought in a further A$74.6 million.

The current figure is established. Amaero Inc. was admitted to the ASX official list on 11 June 2026 with 953,327,200 CDIs quoted, equivalent to 23,833,180 fully paid ordinary shares at the 40 to 1 ratio. The pre scheme count in Amaero Ltd was 952,933,460 shares.

At the ASX quote of A$0.245, 953.3 million CDIs implies a market capitalization of approximately A$234 million, or roughly US$161 million at prevailing rates. That is the number to work with, and it is derived from a filing rather than a data vendor.

It also frames the dilution history plainly. Amaero listed in December 2019 with 77,073,938 quoted shares and 174,853,651 in total. It arrives at its US listing attempt with 952,933,460. The share count rose monotonically for six and a half years. There was never a consolidation, which means every one of those raises landed on existing holders undiluted by any offsetting mechanic.

The 40 to 1 CDI ratio is the exception, and the scheme booklet is candid about what it is. It describes the exchange ratio as effecting an "implicit consolidation." Functionally it is a forty to one reverse split executed through a redomiciliation, which is how a security priced at twenty four Australian cents becomes a security priced near seven US dollars without a separate consolidation vote.

The ownership structure is concentrated and you should know the shape of it.

Pegasus, the fund led by chairman and chief executive Hank Holland, has led three capital raises for Amaero and owns approximately 28 percent of fully paid ordinary shares, rising to approximately 42 percent on a fully converted, fully diluted basis. Holland's disclosed personal interests at the FY2025 report were 196,291,635 ordinary shares and 171,451,503 options over ordinary shares.

That option position is large enough to require thought. A holder with 171 million options against a base of 690 million shares represents meaningful potential dilution, and the gap between 28 percent outright and 42 percent fully diluted quantifies it. The favourable reading is that the chief executive's fund has repeatedly underwritten the company's capital needs and is aligned with a much higher share price. The unfavourable reading is that a single holder controls a blocking position today and would control something close to a majority on full conversion.

Both readings are correct. Which one dominates depends entirely on what happens to the share price between here and the option expiries, and I do not have the full exercise price and expiry schedule.

One small data point on incentive alignment worth recording: on 2 August 2026 the company filed an Appendix 3H notifying that 166,590 options had ceased because the conditions attaching to them "have not been, or have become incapable of being, satisfied." Some performance hurdle was missed. It is a tiny number of options and I would not build anything on it, but it is evidence the performance conditions are real rather than decorative.

The fires

On 13 May 2026, a flash fire occurred during manufacturing operations at the Tennessee facility, resulting in injuries to two production team members.

I am not going to soften that. Two people were hurt.

The company states the incident was contained to a small area with no damage to the facility or manufacturing equipment. Subsequently, an unrelated flash fire occurred in the facility's exhaust system, with no injuries and no damage.

Amaero's response was to engage Jensen Hughes, a safety and risk based engineering consultancy, to conduct a comprehensive review of facility design, engineering controls and process safety, and to pause titanium powder production for approximately six weeks. Refractory powder production and PM-HIP manufacturing continued throughout, including completion of a A$4.6 million refractory powder order for Titomic. Titanium production resumed on 9 July 2026.

Two facts from the recovery are worth stating because they are the ones that tell you whether the damage was commercial as well as physical. During the six week pause there were no purchase order cancellations and no employee attrition. The financial impact was A$1.3 million of revenue deferred into Q1 FY2027 and A$0.4 million of direct incident related cost.

Fine metal powder is combustible. Titanium powder is more than combustible, it is pyrophoric in the right particle size distribution and oxygen concentration, and flash fire is the characteristic failure mode of powder handling operations. This is a known hazard class with established engineering controls, and the fact that a powder producer had a powder fire is not evidence of unusual negligence.

What I would want to know, and cannot determine from public filings, is whether OSHA opened an inspection, what it found, and whether the Jensen Hughes recommendations have been fully implemented or merely accepted. An injury accident at a facility that is simultaneously seeking to expand its role in the naval nuclear supply chain is not a small governance matter, because the customer in question audits its suppliers.

I will file a records request and report what comes back in a later part.

Testing the claim

Amaero describes itself, in the boilerplate at the foot of every announcement, as "a leading U.S. domestic producer of high-value refractory and titanium alloy powders."

I want to test that sentence, because the difference between "a leading producer" and "the only producer" is the difference between a good business and a monopoly, and small cap narratives have a habit of drifting from the first to the second.

It does not survive as a monopoly claim. It survives comfortably as written.

6K Additive, based in North Andover, Massachusetts, produces C103 spherical powder using its UniMelt microwave plasma process. It was selected by America Makes for the Powder Alloy Development for Additive Manufacturing project, part of a US$6 million programme funded by the Air Force Research Laboratory, specifically covering C103. That is a directly competitive US producer with directly competitive government backing.

Elmet Technologies produces C103 niobium alloy powder for laser powder bed fusion and is a fully integrated US company with facilities in Maine, Ohio and Michigan. AP&C, part of the Colibrium Additive business, lists niobium C-103 in its powder catalogue.

So Amaero is one of at least three or four producers of C103 powder with a United States footprint. The company's own wording is careful and accurate: "a leading" producer, not "the only" one. If you encounter research on this name that claims sole source status for C103, that research is wrong, and you should discount everything else in it accordingly.

Where Amaero does look genuinely differentiated is not in the alloy but in the combination. It runs refractory and titanium atomization at production scale, and it runs PM-HIP, in one facility, in the United States, with a naval nuclear prime already partway through qualifying it. I have not found another company with that specific stack. The moat, if there is one, is the qualification position and the second business line, not the chemistry. The chemistry is in the literature and has been since the Johnson administration.

There is one more competitive note worth recording. Trade press reports that Amaero completed qualification of a C103 powder for ADDMAN, which suggests the customer list extends beyond the names in the ASX announcements. I have not verified this against a primary source.

What has actually been signed

Because the distinction between announced, contracted, and delivered is where small cap theses go to die, here is the ledger in one place.

Read the type column rather than the value column. Exactly one line in that table, the A$7.8 million master purchasing agreement, carries a stated minimum commitment. The Velo3D headline is a demand estimate. The Department of War contract is a real signed development programme with milestone payments. The BPMI award is a real production order for a very small amount of money attached to a very large stated requirement. The UPM agreement is a distribution deal with a 4,000 kilogram opening order and a contracted minimum inventory.

That is a more solid book than most companies of this size have. It is not the same thing as A$35 million of contracted Velo3D revenue, which is how this company is most often described.

What would break this

I have tried to write the bear case as if I were short.

The financing risk is first and it is not subtle. Two and a quarter quarters of operating runway on the company's own disclosure, less than that on any measure that includes capital expenditure, interest payments beginning 30 September 2026, principal beginning 30 September 2027, and a capital raise that is contingent on an SEC review process the company does not control. If the IPO window closes, the alternative is another dilutive placement into an ASX market that has already absorbed A$74.6 million of financing in one year. The FY2025 pattern of roughly 148 million new shares in a year gives you the shape of what that looks like.

Customer concentration is second, and it is worse than the headline suggests. The largest publicised relationship is with a company that has never reported positive gross margin, carries going concern language in its own risk factors, did not file the agreement as a material contract, and does not mention Amaero anywhere in its annual report. The most strategically important relationship, BPMI, has so far produced US$344,000 of production revenue. The gap between the strategic story and the invoiced revenue is wide in both directions.

Third, revenue lumpiness. A business that went 4.7, 3.1, 2.6, 7.8 across four quarters is a business where a single delayed shipment moves the quarter. The company is guiding to a growing backlog, but A$12.9 million of that backlog is scheduled into a single half year and any slippage lands visibly.

Fourth, and this is the one I think is most underrated, the difference between capacity and utilization. Amaero has built 680 tonnes per year of installed capacity and sold A$18.1 million of product. Fixed cost absorption at that utilization is poor, and the company does not disclose gross margin in the quarterly, which is itself worth noticing. Until we see a gross margin line, the operating leverage argument is an assertion.

Fifth, hafnium. The Department of War is paying Amaero to reduce reliance on foreign raw material sources. That is the government telling you the input chain has a problem. Amaero has not disclosed secured hafnium or niobium supply arrangements, and a powder producer without secured inputs is a converter exposed on both sides.

Sixth, the safety record. Two injured workers in May, two fires, an independent engineering review, and a customer base that audits suppliers.

Seventh, dilution and control. Forty two percent fully diluted for a single holder aligned with the chief executive.

Eighth, and least quantifiable, the possibility that hypersonics demand for C103 is a narrative rather than a purchase order stream. C103 is an outstanding vacuum nozzle material with sixty years of flight heritage. Its atmospheric oxidation behaviour is a genuine limitation for sustained airbreathing hypersonic flight, and the coating is a life limiter. A programme funded specifically to develop alternatives to it is not an unambiguous endorsement of its future volume.

What would make it work

The bull case does not require heroic assumptions, which is what makes it interesting.

It requires the BPMI relationship to progress from low rate initial production to production rates against a stated requirement of up to 400 components per year. It requires the IPO to complete inside the guided window at a valuation that reflects US defense materials comparables rather than ASX small cap industrials. It requires utilization on 680, eventually 920, tonnes of installed capacity to rise against a capital base that is already spent. And it requires the FOCI work to convert into the classified contracts the company has now twice told us it is pursuing.

Notice that three of those four are things the company has already substantially de risked. The capital is spent. The redomiciliation is done. The audit is done. The submission is in. What remains is conversion.

The asymmetry, stated plainly: this is a company whose strategic position is materially further along than its income statement, trading on an exchange where its natural buyer base cannot reach it, with a catalyst that mechanically fixes the second problem inside twelve months.

The risk, stated equally plainly: it has to get there on about two quarters of cash.

Where I stand

I do not have a position in Amaero and I am not initiating one today.

The reason is not the thesis. The thesis is the most interesting one I have looked at this quarter. The reason is two unresolved facts and one execution problem.

The first unresolved fact is gross margin. Amaero does not disclose it quarterly. The entire operating leverage argument, which is the argument for owning a company with 680 tonnes of capacity and A$18.1 million of revenue, rests on a line item that has not been published. I can see revenue and I can see cash burn. I cannot see what the revenue earns before overhead, and at low utilization that number can be almost anything.

The second is raw material supply. Amaero has disclosed no hafnium or niobium sourcing arrangements. In a market where the input has risen eightfold since 2020 and world production is roughly seventy five tonnes, a converter without disclosed supply security is carrying a risk I cannot size.

The execution problem is the relationship between the two tickers, and it is the practical thing most readers will care about.

The ASX quote is A$0.245. The American over the counter line, AMROF, last printed at US$0.235. At prevailing exchange rates those do not reconcile. A$0.245 converts to roughly US$0.17. AMROF is quoting something like a thirty five percent premium to its own primary listing.

That gap is far too wide to be settlement friction, and the explanation is almost certainly that AMROF is thin enough that its last print is stale, wide, or both. This is the standard trap in dual listed micro caps. The ASX line is where the price is set, by Australian investors, during Australian hours, in Australian dollars. AMROF is a derivative of that price and its quote is only as good as its last trade.

If you are going to own this, own it knowing that. Watch 3DA, convert at spot, and treat any AMROF print above that as an offer rather than a price. Never pay through the primary line. The one structural comfort is that this arbitrage has a defined end date, because a US listing collapses the two quotes into one.

I would rather be early on a company like this than right about a company like this, so let me say plainly what would move me from watching to owning: a published gross margin above roughly thirty percent, disclosure of secured hafnium supply, or the S-1 going public. Any one of the three.

What I want before I act: the Form S-1 when it goes public, which resolves the share count, the margin structure, the customer concentration disclosure and the risk factors in one document. It also, being an SEC registration rather than an ASX release, will be written by lawyers with a materially different liability exposure.

The catalyst calendar between now and then, as best I can construct it: FY2026 annual report and audited accounts, expected September 2026 based on the prior year's 18 September filing. First interest payment on the EXIM facility, 30 September 2026. Q1 FY2027 quarterly and Appendix 4C, expected late October 2026, which is the first clean look at post incident production and will contain the A$1.3 million of deferred titanium revenue. The public flip of the S-1, expected on the company's own guidance in late calendar 2026 or early 2027. Completion of the Department of War programme, August 2027.

The one I would watch hardest is the October quarterly, because it will contain the first cash figure after the capital programme closed, and it will tell you whether the burn rate normalizes now that the one off IPO and redomiciliation costs are behind it. Item 8.5 in that document is the single most informative number this company publishes.

Part 2 will cover the S-1 when it becomes public, the hafnium and niobium input chain in detail, the full BPMI contract history if I can reconstruct it from federal procurement records, and the OSHA record on the May incidents.

I have no position in Amaero, Velo3D, or any company named in this piece. This is not investment advice. The company is loss making, has negative operating cash flow, and states on its own filing that it has approximately 2.28 quarters of funding available.

References

Amaero Inc., Quarterly Activities Report and Appendix 4C for the period ending 30 June 2026, ASX announcement 22 July 2026.

Amaero Inc., Investor Presentation, ASX announcement 21 July 2026.

Amaero Inc., Board Update, ASX announcement 4 August 2026.

Amaero Inc., Final Director's Interest Notice, Jamie Levy and Alistair Cray, ASX announcements 4 August 2026.

Amaero Inc., Notification of cessation of securities, Appendix 3H, ASX announcement 3 August 2026.

Amaero Inc., Submission of Draft Registration for IPO, ASX announcement 15 July 2026.

Amaero Inc., Amaero Awarded A$6.5 Million Contract from U.S. Department of War, ASX announcement 22 July 2026.

Amaero Inc., Piping Contract Awarded from BPMI for Submarine Industrial Base, ASX announcement 1 July 2026.

Amaero Inc., Amaero Resumes Titanium Powder Production, ASX announcement 9 July 2026.

Amaero Inc., Amaero Comments on Incident at Factory, ASX announcement 15 May 2026.

Amaero Inc., Update on Tennessee Manufacturing Facility, ASX announcement 27 May 2026.

Amaero Inc., Amaero Expands Powder Capacity Ahead of Schedule, ASX announcement 22 June 2026.

Amaero Inc., Amaero Re-domiciliation, Schemes become Effective, ASX announcement 11 June 2026.

Amaero Inc., United States Navy Issues Letter of Support, ASX announcement 15 December 2025.

Amaero Inc., Amaero Signs Supplier Agreement with A$7.8M Order for Titanium Powders, ASX announcement 10 April 2026.

Amaero Inc., Credit Agreement Signed for US$22.8 Million Loan from Export-Import Bank, ASX announcement 26 February 2025.

Amaero Ltd, Annual Report 2025, ASX announcement 18 September 2025.

Velo3D Inc., Form 8-K and supplementary slides, SEC accession 0000950170-25-070439, filed 13 May 2025.

Velo3D Inc., Form 8-K and supplementary slides, SEC accession 0000950170-25-104039, filed 6 August 2025.

Velo3D Inc., Form 10-K for fiscal year 2025, filed 31 March 2026, commitments and contingencies note.

Velo3D Inc., Form 10-Q for the first quarter of 2026, commitments and contingencies note.

Velo3D Inc., SEC company submissions record, CIK 0001825079.

Amaero, Amaero Signs Long-Term, Exclusive Supply Agreement with Velo3D, announcement 29 April 2025.

Velo3D Inc., Velo3D Announces $22 Million Long-Term Exclusive Supply Agreement, announcement 29 April 2025.

Amaero, Velo3D Qualification Condition Satisfied for C103, announcement 8 July 2025.

Amaero International Ltd, prospectus dated 29 October 2019, sections covering Monash intellectual property licence agreements.

Amaero Inc., Scheme Booklet, distributed May 2026, including CDI ratio and implicit consolidation disclosure.

ASX admission notice, Amaero Inc., 11 June 2026, 953,327,200 CDIs quoted.

United States Geological Survey and industry trade estimates for hafnium production, concentration and pricing, 2024 to 2026.

6K Additive, niobium alloy powder C103 product documentation and America Makes PADAM award announcement.

Elmet Technologies, C103 niobium additive manufacturing powder product documentation.

Amaero investor archive, investorhub.amaero.com.au, 659 announcements reviewed.